CLINICAL_TRIALS
trial_result
· 2017-11-13
Clinical Trial Update: Biosignatures of Latuda for Bipolar Depression [NA]
Summary
A completed clinical trial evaluating biosignatures of Latuda (lurasidone) for bipolar depression, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Bipolar Depression | NA | Status: COMPLETED | Results posted: 2017-11-13